CDKAL1 rs10946398: Understanding Your Genetic Association
The rs10946398 variant is a common single-nucleotide polymorphism located within the CDKAL1 gene. Research has associated this genetic marker with variations in insulin secretion and an increased susceptibility to type 2 diabetes.
What each genotype means
Increased diabetes risk profile
Research indicates that this genotype is associated with an increased risk of developing type 2 diabetes and may influence post-transplant diabetes development in specific clinical contexts. The CDKAL1 gene plays a role in pancreatic beta-cell function, and this variant is linked to impaired insulin secretion. Please discuss your metabolic health and any concerns regarding diabetes risk with your healthcare provider.
This is a common genotype found in many global populations, though exact frequencies vary significantly by ancestry.
Intermediate risk profile
This genotype represents a heterozygous state for the CDKAL1 variant, which is associated with variations in insulin secretion and type 2 diabetes susceptibility. Individuals with this profile may have an intermediate risk compared to those with the homozygous risk genotype. Please consult with your clinician to discuss your overall metabolic health and appropriate screening measures.
This genotype is frequently observed across diverse populations as a common variation.
Baseline risk profile
This genotype is generally considered the baseline or non-risk state in the context of studies examining the CDKAL1 variant's association with type 2 diabetes. While this specific genotype is not linked to the increased risk observed with the other allele, overall diabetes risk is influenced by a combination of many genetic and lifestyle factors. Always consult with a healthcare professional for personalized medical advice or health assessments.
This genotype is common and widely distributed across various ancestral groups.
What is rs10946398?
The rs10946398 variant is a single-nucleotide polymorphism (SNP), which is a variation at a single position in the DNA sequence. This specific SNP is located within the CDKAL1 gene, which stands for CDK5 regulatory subunit associated protein 1-like 1. In the context of human genetics, SNPs like rs10946398 are often studied to understand how small differences in our genetic code contribute to complex traits and disease risks. Because this variant is common, it has been the subject of numerous genome-wide association studies (GWAS) aimed at identifying the genetic architecture of metabolic conditions. It is important to note that identifying a SNP in a specific gene does not mean the SNP itself causes a disease; rather, it serves as a marker that may be statistically linked to certain physiological outcomes, such as how the body manages blood glucose levels.
The Role of the CDKAL1 Gene
The CDKAL1 gene provides instructions for making a protein that is structurally similar to proteins involved in regulating cell division. However, its primary function in the context of metabolic health is linked to the pancreas. Research suggests that the CDKAL1 protein plays a critical role in the function of pancreatic beta-cells, which are the cells responsible for producing and secreting insulin. Insulin is the hormone that allows cells to take up glucose from the bloodstream. When beta-cell function is impaired, the body may struggle to produce enough insulin to maintain healthy blood sugar levels. Studies have indicated that CDKAL1 may act as a sensor for glucotoxicity, helping the cell manage stress. Variations in this gene are thought to influence the efficiency of insulin secretion, which is a key factor in the development of type 2 diabetes.
Research and Evidence Strength
The association between rs10946398 and type 2 diabetes is supported by moderate evidence from multiple large-scale genetic studies. Since its initial identification in genome-wide association studies, researchers have consistently observed that certain alleles of this SNP correlate with reduced insulin response. For example, some studies have reported that individuals carrying specific risk alleles show a measurable decrease in insulin secretion compared to those who do not. While these statistical associations are robust across various populations, the effect size of any single SNP is typically small. Type 2 diabetes is a complex, polygenic condition, meaning it is influenced by hundreds of genetic variants, environmental factors, lifestyle, and diet. Therefore, while rs10946398 is a recognized marker in diabetes research, it is only one piece of a much larger biological puzzle.
Interpreting Your Genetic Information
Understanding your genotype for rs10946398 provides insight into your genetic predisposition, but it is not a diagnostic tool. Genetic associations are based on population-level data and cannot predict an individual's health outcome with certainty. Many people with 'risk' genotypes never develop diabetes, and many without them do. If you are concerned about your metabolic health, the most effective steps involve focusing on modifiable factors such as maintaining a balanced diet, regular physical activity, and routine health screenings. If you have questions about how your genetic profile might influence your response to specific medications or your overall risk profile, you should discuss this information with a qualified clinician or pharmacist. They can help interpret these findings in the context of your personal medical history and current health status.
How common is this variant?
The rs10946398 variant is considered a common polymorphism, with its allele frequencies varying across different global ancestral populations.
Frequently asked questions
Does having the risk genotype mean I will get diabetes?
No. Genetic associations indicate a statistical trend in a population, not a certainty for an individual. Type 2 diabetes is influenced by many factors, including lifestyle, diet, and other genetic variants.
Can I use this information to change my diet?
While genetic information is interesting, dietary changes should be based on your current health status and professional medical advice. Always consult with a doctor or a registered dietitian before making significant changes to your nutrition plan.
Is this variant related to insulin resistance?
Research primarily links CDKAL1 variants to impaired insulin secretion from pancreatic beta-cells rather than insulin resistance. Insulin resistance and impaired secretion are distinct but related mechanisms in diabetes development.
Should I get tested for this SNP?
Routine testing for this specific SNP is not currently recommended for clinical diagnosis. If you have concerns about your diabetes risk, standard clinical tests like fasting blood glucose or HbA1c are the appropriate tools for assessment.
Sources & further reading
Educational information only, last refreshed 10/13/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs10946398?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CDKAL1
This SNP is a well-known marker associated with type 2 diabetes risk and impaired insulin secretion.
Intronic regulatory variant linked to quantitative variation in fasting insulin levels and insulin secretion traits.
Associated with impaired insulin secretion and increased risk of type 2 diabetes across multiple global populations.